Phase II study of sorafenib in patients with metastatic or recurrent sarcomas

Robert G. Maki, David R. D'Adamo, Mary L. Keohan, Michael Saulle, Scott M. Schuetze, Samir D. Undevia, Michael B. Livingston, Matthew M. Cooney, Martee L. Hensley, Monica M. Mita, Chris H. Takimoto, Andrew S. Kraft, Anthony D. Elias, Bruce Brockstein, Nathalie E. Blachère, Mark A. Edgar, Lawrence H. Schwartz, Li Xuan Qin, Cristina R. Antonescu, Gary K. Schwartz

Research output: Contribution to journalArticlepeer-review

437 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of sorafenib in patients with metastatic or recurrent sarcomas'. Together they form a unique fingerprint.

Medicine & Life Sciences